Roche Sequencing Usa company information, Employees & Contact Information

Reminder: Invitation to Roche’s 3rd Quarter Sales 2025 Presentation Roche

Changes to the Roche Enlarged Corporate Executive Committee GlobeNewswire

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology Investing News Network

Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test PR Newswire

Roche 2025: Playing the long game PharmaLive

Roche Collaborates with OASES to Drive Primary Healthcare Transformation and Innovation, Strengthening Hong Kong's Position as a Global Healthcare Hub Laotian Times

Roche’s phase III evERA data showed giredestrant GlobeNewswire

Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025 PR Newswire

Roche’s Annual Report 2024 Roche

Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV PR Newswire

Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years GlobeNewswire

Are we overlooking the true value of innovation? Roche

Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire

Roche commences tender offer for all shares of 89bio, Inc. GlobeNewswire

AI and machine learning: Revolutionising drug discovery and transforming patient care Roche

CHMP recommends EU approval of Roche’s subcutaneous GlobeNewswire

Clever delivery Roche

Positive phase III results show Roche’s giredestrant GlobeNewswire

African Genomics Program Roche

Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub Investing News Network

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine) GlobeNewswire

Roche receives CE mark for Contivue, its Port Delivery GlobeNewswire

Roche receives FDA 510(k) clearance for the first blood test in the U.S. measuring Lp(a) in molar units PR Newswire

Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU GlobeNewswire

Roche presents new insights in Alzheimer’s disease research GlobeNewswire

Roche’s Susvimo maintains vision over five years with two GlobeNewswire

From misdiagnosed heart attack to patient advocacy superhero Roche

European Commission approves Roche’s Itovebi for people GlobeNewswire

Roche Diagnostics Achieves Vitamin D Total Test InkFreeNews.com

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides GlobeNewswire

Roche to advance prasinezumab into Phase III development for early-stage Parkinson's disease GlobeNewswire

Early data suggest Roche’s NXT007 may have the potential to GlobeNewswire

Roche receives FDA approval for the VENTANA MET (SP44) RxDx GlobeNewswire

Roche Elecsys sFlt-1/PlGF ratio for preeclampsia receives FDA 510(k) clearance, offering a fast and reliable way to predict the risk of developing severe preeclampsia PR Newswire

Roche’s fenebrutinib maintains near-complete suppression of GlobeNewswire

Aakash Desai: Roche received Breakthrough Device Designation from the FDA for the VENTANA TROP2 RxDx Device Oncodaily

Roche provides update on FDA Advisory Committee meeting on GlobeNewswire

First-Ever Mass Spectrometry Test Achieves CLIA Moderate Status: Roche's Breakthrough in Lab Testing Stock Titan

Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity GlobeNewswire

Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management Pharmaceutical Executive

Roche’s Annual Report 2023 Roche

Roche Appoints Wafaa Mamilli as Chief Digital Technology Officer Pharmaceutical Executive

Our strategy Roche

About Roche Roche

Pharma solutions Roche

Roche's Annual Report 2022 Roche

Our History Roche

Roche Announces $550 Million Indianapolis Investment InkFreeNews.com

Privacy notice Roche

Partnering Roche

Sustainability Roche

Accessibility statement Roche

The imCORE Network: Experts collaborating to fight cancer Roche

Roche AI Strategy: Analysis of Sustained Dominance in Pharma AI Klover.ai

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology GlobeNewswire

Media Library Roche

Innovation Roche

Solutions Roche

Media Roche

Drug safety at Roche Roche

Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA PR Newswire

Calculating the unimaginable Roche

The history - and future - of blood glucose monitoring Roche

9 things you may not know about cancer Roche

Annual General Meeting Roche

Pharma partnering in Asia Roche

Innovation process Roche

Bridging the innovation-regulation gap Roche

Animal Research Roche

Kadcyla (trastuzumab emtansine) Roche

Biotechnology: CrossMAb technology Roche

Modeling the future Roche

Fighting cervical cancer around the globe Roche

New era of antibiotics potentially in sight after more than 50 years Roche

If you can’t test, you can’t treat Roche

Legal Statement Roche

The promise of growing a human organ-on-a-chip Roche

A future free from cervical cancer Roche

Privacy notice for pharmacovigilance, medical information and product complaints Roche

World Economic Forum shines a light on Roche’s Digitization efforts Roche

Harnessing the power of AI Roche

Bringing patient support to a rare disease Roche

Science and the City: Basel Roche

Our business Roche

Live well, work well Roche

It takes the power of partnership Roche

Optimising clinical decision-making with medical algorithms Roche

Governance Roche

Roche provides update on phase III study of TECENTRIQ® (atezolizumab) in people with previously treated advanced bladder cancer Roche

Roche to acquire Viewics, Inc. to provide data-driven lab business analytics and add further digital capabilities along the laboratory value chain Roche

Rare diseases are not rare Roche

Roche launches Pilot brand, expands retail channels for COVID-19 At-Home Test PR Newswire

Roche introduces the navify brand for its digital health solutions at HLTH 2022 PR Newswire

Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo PR Newswire

Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024 PR Newswire

Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023 Yahoo Finance

Results of a six-month study combining Roche’s Esbriet with nintedanib in patients with IPF presented at ERS Roche

Stamping out Hepatitis C in Egypt and Pakistan Roche

Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care GlobeNewswire

Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment PR Newswire